These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Infectivity of murine papillomavirus in the surgical byproducts of treated tail warts. Best SR; Esquivel D; Mellinger-Pilgrim R; Roden RBS; Pitman MJ Laryngoscope; 2020 Mar; 130(3):712-717. PubMed ID: 31041820 [TBL] [Abstract][Full Text] [Related]
30. Concurrent oral human papilloma virus infection in patients with recurrent respiratory papillomatosis: a preliminary study. Born H; Ruiz R; Verma A; Taliercio S; Achlatis S; Pitman M; Gandonu S; Bing R; Amin MR; Branski RC Laryngoscope; 2014 Dec; 124(12):2785-90. PubMed ID: 25059492 [TBL] [Abstract][Full Text] [Related]
31. Prevalence and clinical implications of low-risk human papillomavirus among patients with recurrent respiratory papillomatosis in Rio de Janeiro, Brazil. Figueiredo MC; Justino MC; Delmonico L; Silvestre RT; de Castro TL; Dos Santos Moreira A; Macedo JMB; da Costa Carvalho MDG; Scherrer L; de Medeiros Lima DJM; Alves G; Ornellas MH Auris Nasus Larynx; 2019 Aug; 46(4):570-575. PubMed ID: 30581074 [TBL] [Abstract][Full Text] [Related]
32. [Prevalence of human papillomavirus infection in squamous cell carcinoma of the oral cavity, oropharynx and larynx]. Villagómez-Ortíz VJ; Paz-Delgadillo DE; Marino-Martínez I; Ceseñas-Falcón LÁ; Sandoval-de la Fuente A; Reyes-Escobedo A Cir Cir; 2016; 84(5):363-8. PubMed ID: 27032466 [TBL] [Abstract][Full Text] [Related]
33. Role of E6 in Maintaining the Basal Cell Reservoir during Productive Papillomavirus Infection. Saunders-Wood T; Egawa N; Zheng K; Giaretta A; Griffin HM; Doorbar J J Virol; 2022 Mar; 96(5):e0118121. PubMed ID: 35019722 [TBL] [Abstract][Full Text] [Related]
34. Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice. Scagnolari C; Cannella F; Pierangeli A; Mellinger Pilgrim R; Antonelli G; Rowley D; Wong M; Best S; Xing D; Roden RBS; Viscidi R J Virol; 2020 Jun; 94(12):. PubMed ID: 32295905 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of Cellular MEK/ERK Signaling Suppresses Murine Papillomavirus Type 1 Replicative Activities and Promotes Tumor Regression. Luna AJ; Young JM; Sterk RT; Bondu V; Schultz FA; Kusewitt DF; Kang H; Ozbun MA bioRxiv; 2023 Apr; ():. PubMed ID: 36993217 [TBL] [Abstract][Full Text] [Related]